DK1171108T3 - Kombinationspræparat til behandling af malaria - Google Patents

Kombinationspræparat til behandling af malaria

Info

Publication number
DK1171108T3
DK1171108T3 DK00921746T DK00921746T DK1171108T3 DK 1171108 T3 DK1171108 T3 DK 1171108T3 DK 00921746 T DK00921746 T DK 00921746T DK 00921746 T DK00921746 T DK 00921746T DK 1171108 T3 DK1171108 T3 DK 1171108T3
Authority
DK
Denmark
Prior art keywords
treatment
malaria
combination preparation
proguanil
primaquine
Prior art date
Application number
DK00921746T
Other languages
Danish (da)
English (en)
Inventor
Jeffrey David Chulay
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK1171108T3 publication Critical patent/DK1171108T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00921746T 1999-04-09 2000-04-05 Kombinationspræparat til behandling af malaria DK1171108T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12867299P 1999-04-09 1999-04-09
PCT/US2000/009091 WO2000061133A1 (en) 1999-04-09 2000-04-05 Combination preparation for treating malaria

Publications (1)

Publication Number Publication Date
DK1171108T3 true DK1171108T3 (da) 2003-10-06

Family

ID=22436426

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00921746T DK1171108T3 (da) 1999-04-09 2000-04-05 Kombinationspræparat til behandling af malaria

Country Status (24)

Country Link
US (1) US6413993B1 (ja)
EP (1) EP1171108B1 (ja)
JP (1) JP2002541196A (ja)
KR (1) KR100613805B1 (ja)
CN (1) CN1152676C (ja)
AT (1) ATE241971T1 (ja)
AU (1) AU758167B2 (ja)
BR (1) BR0009676A (ja)
CA (1) CA2369089A1 (ja)
CZ (1) CZ294903B6 (ja)
DE (1) DE60003175T2 (ja)
DK (1) DK1171108T3 (ja)
ES (1) ES2199817T3 (ja)
HK (1) HK1041638A1 (ja)
HU (1) HUP0200842A3 (ja)
IL (2) IL145609A0 (ja)
MX (1) MXPA01010125A (ja)
NO (1) NO20014806L (ja)
NZ (1) NZ514353A (ja)
PL (1) PL350987A1 (ja)
PT (1) PT1171108E (ja)
TR (1) TR200102843T2 (ja)
WO (1) WO2000061133A1 (ja)
ZA (1) ZA200108254B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
MX2010012261A (es) * 2008-05-09 2011-04-07 Tolmar Inc Proguanil para tratar enfermedades de la piel/mucosa.
CN102105427A (zh) * 2008-07-25 2011-06-22 阿尔法制药有限公司 粒度直径范围(D90)为大于3μm至约10μm的阿托伐醌
EP2467358B1 (en) * 2009-08-20 2014-07-23 IPCA Laboratories Limited Novel complex for treatment and/or prophylaxis of parasitic infections
WO2017138652A1 (ja) * 2016-02-12 2017-08-17 花王株式会社 メラニン分解抑制剤
WO2018204563A1 (en) * 2017-05-03 2018-11-08 The Johns Hopkins University Intramuscular atovaquone for malaria prophylaxis
CN107737108B (zh) * 2017-12-17 2018-06-26 姚蕾 一种治疗心肌梗死后心室重塑的口服药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
JPH0873355A (ja) * 1994-09-02 1996-03-19 Mitsui Toatsu Chem Inc 抗マラリア薬耐性克服剤

Also Published As

Publication number Publication date
NO20014806D0 (no) 2001-10-03
ZA200108254B (en) 2003-03-26
CZ294903B6 (cs) 2005-04-13
CN1152676C (zh) 2004-06-09
BR0009676A (pt) 2002-09-03
PL350987A1 (en) 2003-02-24
CN1346267A (zh) 2002-04-24
HUP0200842A2 (hu) 2002-07-29
US6413993B1 (en) 2002-07-02
HK1041638A1 (en) 2002-07-19
MXPA01010125A (es) 2002-06-04
KR20010108468A (ko) 2001-12-07
NO20014806L (no) 2001-12-05
DE60003175D1 (de) 2003-07-10
IL145609A (en) 2006-04-10
ES2199817T3 (es) 2004-03-01
EP1171108B1 (en) 2003-06-04
CA2369089A1 (en) 2000-10-19
CZ20013646A3 (cs) 2002-06-12
NZ514353A (en) 2003-10-31
IL145609A0 (en) 2002-06-30
KR100613805B1 (ko) 2006-08-18
WO2000061133A1 (en) 2000-10-19
PT1171108E (pt) 2003-10-31
HUP0200842A3 (en) 2006-07-28
ATE241971T1 (de) 2003-06-15
AU758167B2 (en) 2003-03-20
JP2002541196A (ja) 2002-12-03
TR200102843T2 (tr) 2002-01-21
DE60003175T2 (de) 2004-04-01
EP1171108A1 (en) 2002-01-16
AU4202200A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
GEP20053602B (en) Aripiprazole for Oral Administration
LU91326I2 (fr) Vaccin papillomavirus humain Ä6,11,16,18Ü(recombinant, adsorbé)
BR0108210A (pt) Vacina contra o vìrus da imunodeficiência humana
IL136512A0 (en) Intravenous infusion administration set
DK0998287T3 (da) Anvendelse af levobupivacain
AU2002343321A8 (en) Isolation and purification of p. falciparum merozoite protein-142 vaccine
DK1171108T3 (da) Kombinationspræparat til behandling af malaria
PT966285E (pt) Utilizacao de (+)mefloquina para o tratamento da malaria
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
HK1094807A1 (en) 1-vinylpyrrolidin-2-one/ ester copolymers
AU2002304480A1 (en) Plasmodium falciparum antigens and vaccine and diagnostic uses thereof
AU2003223686A1 (en) Immunogenic agent therapy using plasmapheresis or exchange transfusion
PL367628A1 (en) Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia
HK1039935A1 (en) Use of (1r, 4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol in hbv
MX2007004040A (es) Uso para alfa-simpatomimeticos con estructura de 2-imidazolina.
BR8001273Y1 (pt) suspensório médico.
AU2002328253A1 (en) Pna conjugate for the treatment of diseases associated with hiv
UA32280A (uk) Спосіб формування тонко-товстокишкового анастомозу бік у бік
WO2003059334A3 (en) Gemcitabine in the treatment of smallpox
UA38042A (uk) Протифібриляторний препарат трамадол
PT1383563T (pt) Métodos para o tratamento do hiv e outros vírus
ITMI992410A0 (it) Vaccino per hiv
ZA200301175B (en) Malaria immunogen and vaccine.
AU2002308925A1 (en) Blood group-free human blood plasma and the preparation method thereof
UA32358A (uk) Спосіб лікування гіпертонічної хвороби серця